Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies – Elias Jabbour, MD
Introduction to Emerging Therapies in ALL Management … Dr. Elias Jabbour shared recent developments in the treatment of acute lymphoblastic leukemia (ALL) during a recent medical conference. His presentation focused on the evolving landscape of ALL therapy, particularly emphasizing the growing importance of targeted therapies including bispecific antibodies, antibody-drug conjugates (ADCs), and tyrosine kinase inhibitors